Liver fibrosis and hepatocyte apoptosis are attenuated by GKT137831, a novel NOX4/NOX1 inhibitor in vivo

Mechanisms of Hepatic Fibrogenesis

Friedman, S. L. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.003 · Cited by 2,640 · see citing works

Pathogenesis of Liver Fibrosis

Hernandez-Gea, V., & Friedman, S. L. (2011) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-011110-130246 · Cited by 1,809 · see citing works

NADPH oxidase-4 mediates myofibroblast activation and fibrogenic responses to lung injury

Hecker, L., Vittal, R., Jones, T., Jagirdar, R., Luckhardt, T. R., Horowitz, J. C., Pennathur, S., Martinez, F. J., & Thannickal, V. J. (2009) · Nature Medicine · doi:10.1038/nm.2005 · Cited by 852 · see citing works

Cathepsin B contributes to TNF-α–mediated hepatocyte apoptosis by promoting mitochondrial release of cytochrome c

Guicciardi, M. E., Deussing, J. M., Miyoshi, H., Bronk, S. F., Svingen, P. A., Peters, C., Kaufmann, S. H., & Gores, G. J. (2000) · Journal of Clinical Investigation · doi:10.1172/jci9914 · Cited by 710 · see citing works

Nox4 Is a Protective Reactive Oxygen Species Generating Vascular NADPH Oxidase

Schröder, K., Zhang, M., Benkhoff, S., Mieth, A., Pliquett, R., Kosowski, J., Kruse, C., Luedike, P., Michaelis, U. R., Weissmann, N., et al. (2012) · Circulation Research · doi:10.1161/circresaha.112.267054 · Cited by 622 · see citing works

Mechanisms of Disease Progression in Nonalcoholic Fatty Liver Disease

Jou, J. H., Choi, S. S., & Diehl, A. M. (2008) · Seminars in Liver Disease · doi:10.1055/s-0028-1091981 · Cited by 482 · see citing works

Myofibroblast differentiation during fibrosis: role of NAD(P)H oxidases

Barnes, J. L., & Gorin, Y. C. (2011) · Kidney International · doi:10.1038/ki.2010.516 · Cited by 431 · see citing works

Gene Expression Profiles During Hepatic Stellate Cell Activation in Culture and In Vivo

Minicis, S. D., Seki, E., Uchinami, H., Kluwe, J., Zhang, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.033 · Cited by 425 · see citing works

Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo

Zhan, S.-S., Jiang, J. X., Wu, J., Halsted, C., Friedman, S. L., Zern, M. A., & Torok, N. J. (2006) · Hepatology · doi:10.1002/hep.21093 · Cited by 284 · see citing works

Involvement of NADPH Oxidase Isoforms and Src Family Kinases in CD95-dependent Hepatocyte Apoptosis

Reinehr, R., Becker, S., Eberle, A., Grether‐Beck, S., & Häussinger, D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m414361200 · Cited by 246 · see citing works

First in Class, Potent, and Orally Bioavailable NADPH Oxidase Isoform 4 (Nox4) Inhibitors for the Treatment of Idiopathic Pulmonary Fibrosis

Laleu, B., Gaggini, F., Orchard, M., Fioraso-Cartier, L., Cagnon, L., Houngninou-Molango, S., Gradia, A., Duboux, G., Merlot, C., Heitz, F., et al. (2010) · Journal of Medicinal Chemistry · doi:10.1021/jm100773e · Cited by 243 · see citing works

Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity

Carmona‐Cuenca, I., Roncero, C., Sancho, P., Caja, L., Fausto, N., Fernández, M., & Fabregat, I. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.07.021 · Cited by 222 · see citing works

Cytochrome P450 2E1-derived Reactive Oxygen Species Mediate Paracrine Stimulation of Collagen I Protein Synthesis by Hepatic Stellate Cells

Nieto, N., Friedman, S. L., & Cederbaum, A. I. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m110506200 · Cited by 208 · see citing works

The Nicotinamide Adenine Dinucleotide Phosphate Oxidase Homologues NOX1 and NOX2/gp91phox Mediate Hepatic Fibrosis in Mice

Paik, Y., Iwaisako, K., Seki, E., Inokuchi, S., Schnabl, B., Österreicher, C. H., Kisseleva, T., & Brenner, D. A. (2011) · Hepatology · doi:10.1002/hep.24281 · Cited by 195 · see citing works

Hepatocyte NAD(P)H Oxidases as an Endogenous Source of Reactive Oxygen Species During Hepatitis C Virus Infection

de Mochel, N. S. R., Seronello, S., Wang, S. H., Ito, C., Zheng, J. X., Liang, J. T., Lambeth, D. J., & Choi, J. (2010) · Hepatology · doi:10.1002/hep.23671 · Cited by 183 · see citing works

Apoptotic body engulfment by hepatic stellate cells promotes their survival by the JAK/STAT and Akt/NF-κB-dependent pathways

Jiang, J. X., Mikami, K., Venugopal, S. K., Li, Y., & Torok, N. J. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2009.03.024 · Cited by 155 · see citing works

Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase 2 Plays a Key Role in Stellate Cell Activation and Liver Fibrogenesis In Vivo

Jiang, J. X., Venugopal, S. K., Serizawa, N., Chen, X., Scott, F., Li, Y., Adamson, R. H., Devaraj, S., Shah, V. H., Gershwin, M. E., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.05.074 · Cited by 120 · see citing works

NOX1/nicotinamide adenine dinucleotide phosphate, reduced form (NADPH) oxidase promotes proliferation of stellate cells and aggravates liver fibrosis induced by bile duct ligation

Cui, W., Matsuno, K., Iwata, K., Ibi, M., Matsumoto, M., Zhang, J., Zhu, K., Katsuyama, M., Torok, N. J., & Yabe‐Nishimura, C. (2011) · Hepatology · doi:10.1002/hep.24465 · Cited by 113 · see citing works

Purification of rat hepatic stellate cells by side scatter-activated cell sorting

Geerts, A. E., Niki, T., Hellemans, K., Craemer, D. D., Berg, K. V. D., Lazou, J.-M., Stangé, G. M., Winkel, M. V. D., & Bleser, P. D. (1998) · Hepatology · doi:10.1002/hep.510270238 · Cited by 107 · see citing works

Oxidative and Nitrosative Stress and Fibrogenic Response

Urtasun, R., de la Rosa, L. C., & Nieto, N. (2008) · Clinics in Liver Disease · doi:10.1016/j.cld.2008.07.005 · Cited by 99 · see citing works

Control of Hepatic Nuclear Superoxide Production by Glucose 6-Phosphate Dehydrogenase and NADPH Oxidase-4

Spencer, N. Y., Yan, Z., Boudreau, R. L., Zhang, Y., Luo, M., Li, Q., Tian, X., Shah, A. M., Davisson, R. L., Davidson, B. L., et al. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.193821 · Cited by 97 · see citing works

The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-β-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms

Sancho, P., Bertrán, E., Caja, L., Carmona‐Cuenca, I., Murillo, M. M., & Fabregat, I. (2008) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.09.003 · Cited by 83 · see citing works

Design, synthesis and biological activity of original pyrazolo-pyrido-diazepine, -pyrazine and -oxazine dione derivatives as novel dual nox4/nox1 inhibitors

Gaggini, F., Laleu, B., Orchard, M., Fioraso-Cartier, L., Cagnon, L., Houngninou-Molango, S., Gradia, A., Duboux, G., Merlot, C., Heitz, F., et al. (2011) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2011.10.016 · Cited by 79 · see citing works

Cell Death and Fibrogenesis

Mehal, W. Z., & Imaeda, A. B. (2010) · Seminars in Liver Disease · doi:10.1055/s-0030-1255352 · Cited by 70 · see citing works

Constitutive androstane receptor (CAR) ligand, TCPOBOP, attenuates Fas-induced murine liver injury by altering Bcl-2 proteins

Baskin-Bey, E. S., Huang, W., Ishimura, N., Isomoto, H., Bronk, S. F., Braley, K. E., Craig, R. W., Moore, D. D., & Gores, G. J. (2006) · Hepatology · doi:10.1002/hep.21236 · Cited by 54 · see citing works

Adenosine Inhibits Chemotaxis and Induces Hepatocyte-Specific Genes in Bone Marrow Mesenchymal Stem Cells

Mohamadnejad, M., Sohail, M. A., Watanabe, A., Krause, D. S., Swenson, S. E., & Mehal, W. Z. (2009) · Hepatology · doi:10.1002/hep.23389 · Cited by 27 · see citing works

Liver Fibrosis: Mechanistic Concepts and Therapeutic Perspectives

Roehlen, N., Crouchet, E., & Baumert, T. F. (2020) · Cells · doi:10.3390/cells9040875 · Cited by 1,237 · see citing works

Reciprocal regulation of TGF-β and reactive oxygen species: A perverse cycle for fibrosis

Liu, R.-M., & Desai, L. P. (2015) · Redox Biology · doi:10.1016/j.redox.2015.09.009 · Cited by 710 · see citing works

Molecular pathways of nonalcoholic fatty liver disease development and progression

Bessone, F., Razori, M. V., & Roma, M. G. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2947-0 · Cited by 625 · see citing works

Sources of Vascular Nitric Oxide and Reactive Oxygen Species and Their Regulation

Tejero, J., Shiva, S., & Gladwin, M. T. (2019) · Physiological Reviews · doi:10.1152/physrev.00036.2017 · Cited by 541 · see citing works

NADPH oxidases and oxidase crosstalk in cardiovascular diseases: novel therapeutic targets

Zhang, Y., Murugesan, P., Huang, K., & Cai, H. “. (2019) · Nature Reviews Cardiology · doi:10.1038/s41569-019-0260-8 · Cited by 546 · see citing works

Oxidative stress and pulmonary fibrosis

Cheresh, P., Kim, S.-J., Tulasiram, S., & Kamp, D. W. (2012) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2012.11.021 · Cited by 527 · see citing works

Oxidative Stress in Liver Pathophysiology and Disease

Allameh, A., Niayesh‐Mehr, R., Aliarab, A., Sebastiani, G., & Pantopoulos, K. (2023) · Antioxidants · doi:10.3390/antiox12091653 · Cited by 565 · see citing works

Evolution of nadph oxidase inhibitors: Selectivity and mechanisms for target engagement

Altenhöfer, S., Radermacher, K. A., Kleikers, P. W. M., Wingler, K., & Schmidt, H. H. H. W. (2015) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5814 · Cited by 521 · see citing works

Autoimmune hepatitis

Mieli‐Vergani, G., Vergani, D., Czaja, A. J., Manns, M. P., Krawitt, E. L., Vierling, J. M., Lohse, A. W., & Montaño‐Loza, A. J. (2018) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2018.17 · Cited by 471 · see citing works

Mechanisms of liver fibrosis and its role in liver cancer

Dhar, D., Baglieri, J., Kisseleva, T., & Brenner, D. A. (2020) · Experimental Biology and Medicine · doi:10.1177/1535370219898141 · Cited by 440 · see citing works

NADPH Oxidase 1 Plays a Key Role in Diabetes Mellitus–Accelerated Atherosclerosis

Gray, S. P., Di Marco, E., Okabe, J., Szyndralewiez, C., Heitz, F., Montezano, A. C., de Haan, J. B., Koulis, C., El-Osta, A., Andrews, K. L., et al. (2013) · Circulation · doi:10.1161/circulationaha.112.132159 · Cited by 386 · see citing works

Cellular and molecular mechanisms in the pathogenesis of liver fibrosis: An update

Elpek, G. Ö. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i23.7260 · Cited by 384 · see citing works

Excess TGF-β mediates muscle weakness associated with bone metastases in mice

Waning, D. L., Mohammad, K. S., Reiken, S. R., Xie, W., Andersson, D. C., John, S. K., Chiechi, A., Wright, L. E., Umanskaya, A., Niewolna, M., et al. (2015) · Nature Medicine · doi:10.1038/nm.3961 · Cited by 380 · see citing works

The Role of NADPH Oxidases and Oxidative Stress in Neurodegenerative Disorders

Tarafdar, A., & Pula, G. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19123824 · Cited by 373 · see citing works

Genetic Targeting or Pharmacologic Inhibition of NADPH Oxidase Nox4 Provides Renoprotection in Long-Term Diabetic Nephropathy

Jha, J. C., Gray, S. P., Barit, D., Okabe, J., El-Osta, A., Namikoshi, T., Thallas-Bonke, V., Wingler, K., Szyndralewiez, C., Heitz, F., et al. (2014) · Journal of the American Society of Nephrology · doi:10.1681/asn.2013070810 · Cited by 352 · see citing works

Transforming Growth Factor-β-Induced Cell Plasticity in Liver Fibrosis and Hepatocarcinogenesis

Fabregat, I., & Caballero‐Díaz, D. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00357 · Cited by 352 · see citing works

Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent

Aoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012) · Hepatology · doi:10.1002/hep.25938 · Cited by 336 · see citing works

Oxidative stress in cancer and fibrosis: Opportunity for therapeutic intervention with antioxidant compounds, enzymes, and nanoparticles

Morry, J., Ngamcherdtrakul, W., & Yantasee, W. (2016) · Redox Biology · doi:10.1016/j.redox.2016.12.011 · Cited by 332 · see citing works

European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS)

Egea, J., Fabregat, I., Frapart, Y., Ghezzi, P., Görlach, A., Kietzmann, T., Kubaichuk, K. I., Knaus, U. G., López, M. G., González, G. O., et al. (2017) · Redox Biology · doi:10.1016/j.redox.2017.05.007 · Cited by 311 · see citing works

NADPH oxidase-dependent redox signaling in TGF-β-mediated fibrotic responses

Jiang, F., Liu, G., Dusting, G. J., & Chan, E. C. (2014) · Redox Biology · doi:10.1016/j.redox.2014.01.012 · Cited by 270 · see citing works

Liver fibrosis: Pathophysiology and clinical implications

Berumen, J. A., Baglieri, J., Kisseleva, T., & Mekeel, K. L. (2020) · WIREs Mechanisms of Disease · doi:10.1002/wsbm.1499 · Cited by 276 · see citing works

Matricellular Protein CCN1 Promotes Regression of Liver Fibrosis through Induction of Cellular Senescence in Hepatic Myofibroblasts

Kim, K.-H., Chen, C.-C., Monzon, R. I., & Lau, L. F. (2013) · Molecular and Cellular Biology · doi:10.1128/mcb.00049-13 · Cited by 261 · see citing works

Oxidative Stress Is a Key Modulator in the Development of Nonalcoholic Fatty Liver Disease

Ma, Y., Lee, G., Heo, S.-Y., & Roh, Y. (2021) · Antioxidants · doi:10.3390/antiox11010091 · Cited by 227 · see citing works

Role of NADPH Oxidases in Liver Fibrosis

Paik, Y., Kim, J., Aoyama, T., Minicis, S. D., Bataller, R. A., & Brenner, D. A. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5619 · Cited by 221 · see citing works

NOX4 NADPH Oxidase-Dependent Mitochondrial Oxidative Stress in Aging-Associated Cardiovascular Disease

Vendrov, A. E., Vendrov, K. C., Smith, A., Yuan, J., Sumida, A., Robidoux, J., Runge, M. S., & Madamanchi, N. R. (2015) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6221 · Cited by 219 · see citing works

Liver Fibrosis: Therapeutic Targets and Advances in Drug Therapy

Tan, Z., Sun, H., Xue, T., Gan, C., Liu, H., Xie, Y., Yao, Y., & Ye, T. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.730176 · Cited by 220 · see citing works

Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation

Lan, T., Kisseleva, T., & Brenner, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129743 · Cited by 192 · see citing works

Dissecting fibrosis: therapeutic insights from the small-molecule toolbox

Nanthakumar, C. B., Hatley, R. J. D., Lemma, S., Gauldie, J., Marshall, R. P., & Macdonald, S. J. F. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4592 · Cited by 206 · see citing works

The Role of NADPH Oxidases (NOXs) in Liver Fibrosis and the Activation of Myofibroblasts

Liang, S., Kisseleva, T., & Brenner, D. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00017 · Cited by 192 · see citing works

Targeting nadph oxidase with a novel dual nox1/nox4 inhibitor attenuates renal pathology in type 1 diabetes

Gorin, Y., Cavaglieri, R. C., Khazim, K., Lee, D.-Y., Bruno, F., Thakur, S., Fanti, P., Szyndralewiez, C., Barnes, J. L., Block, K., et al. (2015) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00396.2014 · Cited by 183 · see citing works

Hepatocyte nicotinamide adenine dinucleotide phosphate reduced oxidase 4 regulates stress signaling, fibrosis, and insulin sensitivity during development of steatohepatitis in mice

Bettaieb, A., Jiang, J. X., Sasaki, Y., Chao, T.-I., Kiss, Z., Chen, X., Tian, J., Katsuyama, M., Yabe-Nishimura, C., Xi, Y., et al. (2015) · Gastroenterology · doi:10.1053/j.gastro.2015.04.009 · Cited by 167 · see citing works

NADPH Oxidase NOX4 Mediates Stellate Cell Activation and Hepatocyte Cell Death during Liver Fibrosis Development

Sancho, P., Mainez, J., Crosas-Molist, E., Roncero, C., Fernández-Rodríguez, C., Pinedo, F., Huber, H., Eferl, R., Mikulits, W., & Fabregat, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045285 · Cited by 157 · see citing works

Therapeutic potential of nadph oxidase 1/4 inhibitors

Teixeira, G., Szyndralewiez, C., Molango, S., Carnesecchi, S., Heitz, F., Wiesel, P., & Wood, J. M. (2017) · British Journal of Pharmacology · doi:10.1111/bph.13532 · Cited by 163 · see citing works

Reversal of liver cirrhosis: current evidence and expectations

Jung, Y. K., & Yim, H. J. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.268 · Cited by 152 · see citing works

Role of NADPH oxidases in the redox biology of liver fibrosis

Crosas‐Molist, E., & Fabregat, I. (2015) · Redox Biology · doi:10.1016/j.redox.2015.07.005 · Cited by 149 · see citing works

The nox4 inhibitor gkt137831 attenuates hypoxia-induced pulmonary vascular cell proliferation

Green, D. E., Murphy, T. C., Kang, B.-Y., Kleinhenz, J. M., Szyndralewiez, C., Page, P., Sutliff, R. L., & Hart, C. M. (2012) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2011-0418oc · Cited by 146 · see citing works

Scar management in burn injuries using drug delivery and molecular signaling: Current treatments and future directions

Amini‐Nik, S., Yousuf, Y., & Jeschke, M. G. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.07.017 · Cited by 147 · see citing works

Nox4 and diabetic nephropathy: With a friend like this, who needs enemies?

Gorin, Y. C., & Block, K. L. (2013) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2013.03.014 · Cited by 134 · see citing works

Physiological and pathological functions of NADPH oxidases during myocardial ischemia–reperfusion

Matsushima, S., Tsutsui, H., & Sadoshima, J. (2014) · Trends in Cardiovascular Medicine · doi:10.1016/j.tcm.2014.03.003 · Cited by 132 · see citing works

Targeting Oxidative Stress as a Therapeutic Approach for Idiopathic Pulmonary Fibrosis

Estornut, C., Milara, J., Bayarri, M. A., Belhadj, N., & Cortijo, J. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.794997 · Cited by 135 · see citing works

NADPH Oxidase, NOX1, Mediates Vascular Injury in Ischemic Retinopathy

Wilkinson‐Berka, J. L., Deliyanti, D., Rana, I., Miller, A. G., Agrotis, A., Armani, R., Szyndralewiez, C., Wingler, K., Touyz, R. M., Cooper, M. E., et al. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5357 · Cited by 122 · see citing works

Nox as a target for diabetic complications

Gorin, Y. C., & Block, K. L. (2013) · Clinical Science · doi:10.1042/cs20130065 · Cited by 119 · see citing works

Updates of reactive oxygen species in melanoma etiology and progression

Liu, F., Dellinger, R. W., & Meyskens, F. L. (2014) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2014.04.007 · Cited by 116 · see citing works

An Inhibitor of NADPH Oxidase-4 Attenuates Established Pulmonary Fibrosis in a Rodent Disease Model

Jarman, E. R., Khambata, V. S., Cope, C. L., Jones, P. L., Roger, J., Ye, L. Y., Duggan, N., Head, D., Pearce, A. C., Press, N. J., et al. (2013) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2013-0174oc · Cited by 114 · see citing works

NADPH Oxidase 4 (Nox4) Suppresses Mitochondrial Biogenesis and Bioenergetics in Lung Fibroblasts via a Nuclear Factor Erythroid-derived 2-like 2 (Nrf2)-dependent Pathway

Bernard, K. F., Logsdon, N. J., Miguel, V., Benavides, G. A., Zhang, J., Carter, A. B., Darley-Usmar, V. M., & Thannickal, V. J. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m116.752261 · Cited by 115 · see citing works

Combined NOX1/4 inhibition with GKT137831 in mice provides dose-dependent reno- and atheroprotection even in established micro- and macrovascular disease

Gray, S. P., Jha, J. C., Kennedy, K., van Bommel, E. J. M., Chew, P., Szyndralewiez, C., Touyz, R. M., Schmidt, H. H. H. W., Cooper, M. E., & Jandeleit-Dahm, K. A. M. (2017) · Diabetologia · doi:10.1007/s00125-017-4215-5 · Cited by 109 · see citing works

NADPH oxidases: redox regulation of cell homeostasis and disease

Kračun, D., Lopes, L. R., Cifuentes-Pagano, E., & Pagano, P. J. (2025) · Physiological Reviews · doi:10.1152/physrev.00034.2023 · Cited by 104 · see citing works

Angiotensin-(1–7) Improves Liver Fibrosis by Regulating the NLRP3 Inflammasome via Redox Balance Modulation

Cai, S., Yang, R., Li, Y., Ning, Z., Zhang, L., Zhou, G.-S., Luo, W., Li, D.-H., Chen, Y., Pan, M., et al. (2016) · Antioxidants and Redox Signaling · doi:10.1089/ars.2015.6498 · Cited by 103 · see citing works

Myofibroblasts

Hu, B., & Phan, S. H. (2012) · Current Opinion in Rheumatology · doi:10.1097/bor.0b013e32835b1352 · Cited by 98 · see citing works

Nadph oxidase 1 in liver macrophages promotes inflammation and tumor development in mice

Liang, S., Ma, H.-Y., Zhong, Z., Dhar, D., Liu, X., Xu, J., Koyama, Y., Nishio, T., Karin, D., Karin, G., et al. (2019) · Gastroenterology · doi:10.1053/j.gastro.2018.11.019 · Cited by 92 · see citing works

NOXious signaling in pain processing

Kallenborn-Gerhardt, W., Schröder, K., Geißlinger, G., & Schmidtko, A. (2012) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2012.11.001 · Cited by 91 · see citing works

The NADPH oxidase NOX4 inhibits hepatocyte proliferation and liver cancer progression

Crosas‐Molist, E., Bertrán, E., Sancho, P., López‐Luque, J., Fernando, J., Sánchez, A., Fernández, M., Navarro, E., & Fabregat, I. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.01.040 · Cited by 90 · see citing works

Oxidative stress and hepatic Nox proteins in chronic hepatitis C and hepatocellular carcinoma

Choi, J., Corder, N. L. B., Koduru, B., & Wang, Y. (2014) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2014.04.020 · Cited by 86 · see citing works

Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer

Chen, D., Guo, Z., Yao, L., Sun, Y., Dian, Y., Zhao, D., Ke, Y., Zeng, F., Zhang, C., Deng, G., et al. (2025) · Redox Biology · doi:10.1016/j.redox.2025.103686 · Cited by 88 · see citing works

Antioxidant treatments do not improve force recovery after fatiguing stimulation of mouse skeletal muscle fibres

Cheng, A. J., Bruton, J. D., Lanner, J. T., & Westerblad, H. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2014.279398 · Cited by 86 · see citing works

Linking RAGE and Nox in diabetic micro- and macrovascular complications

Koulis, C., Watson, A. M. D., Gray, S. P., & Jandeleit-Dahm, K. A. M. (2015) · Diabetes & Metabolism · doi:10.1016/j.diabet.2015.01.006 · Cited by 86 · see citing works

The Quest for Selective Nox Inhibitors and Therapeutics: Challenges, Triumphs and Pitfalls

Cifuentes-Pagano, E., Meijles, D. N., & Pagano, P. J. (2014) · Antioxidants & Redox Signaling · doi:10.1089/ars.2013.5620 · Cited by 84 · see citing works

SIRT1–NOX4 signaling axis regulates cancer cachexia

Dasgupta, A., Shukla, S. K., Vernucci, E., King, R. J., Abrego, J., Mulder, S. E., Mullen, N. J., Graves, G., Buettner, K. B., Thakur, R. K., et al. (2020) · The Journal of Experimental Medicine · doi:10.1084/jem.20190745 · Cited by 84 · see citing works

HCV Core Protein Uses Multiple Mechanisms to Induce Oxidative Stress in Human Hepatoma Huh7 Cells

Ivanov, A. V., Smirnova, O. A., Petrushanko, I. Y., Ivanova, O. N., Karpenko, I. L., Alekseeva, E., Sominskaya, I., Makarov, A. А., Bartosch, B., Kochetkov, S. N., et al. (2015) · Viruses · doi:10.3390/v7062745 · Cited by 83 · see citing works

Promising Therapy Candidates for Liver Fibrosis

Wang, P., Koyama, Y., Liu, X., Xu, J., Ma, H., Liang, S., Kim, I. H., Brenner, D. A., & Kisseleva, T. (2016) · Frontiers in Physiology · doi:10.3389/fphys.2016.00047 · Cited by 81 · see citing works

Setanaxib, a first‐in‐class selective NADPH oxidase 1/4 inhibitor for primary biliary cholangitis: A randomized, placebo‐controlled, phase 2 trial

Invernizzi, P., Carbone, M., Jones, D., Levy, C., Little, N., Wiesel, P., Nevens, F., & the study investigators (2023) · Liver International · doi:10.1111/liv.15596 · Cited by 79 · see citing works

Decursin and decursinol angelate: molecular mechanism and therapeutic potential in inflammatory diseases

Shehzad, A., Parveen, S., Qureshi, M., Subhan, F., & Lee, Y. S. (2017) · Inflammation Research · doi:10.1007/s00011-017-1114-7 · Cited by 77 · see citing works

Inhibiting the Activity of NADPH Oxidase in Cancer

Konaté, M. M., Antony, S., & Doroshow, J. H. (2020) · Antioxidants and Redox Signaling · doi:10.1089/ars.2020.8046 · Cited by 77 · see citing works

Pathophysiology and Therapeutic Potential of NADPH Oxidases in Ischemic Stroke‐Induced Oxidative Stress

Duan, J., Gao, S., Tu, S., Lenahan, C., Shao, A., & Sheng, J. (2021) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2021/6631805 · Cited by 76 · see citing works

NADPH Oxidases in Chronic Liver Diseases

Jiang, J. X., & Torok, N. J. (2014) · Advances in Hepatology · doi:10.1155/2014/742931 · Cited by 76 · see citing works

Inhibition of NOX1/4 with GKT137831: a potential novel treatment to attenuate neuroglial cell inflammation in the retina

Deliyanti, D., & Wilkinson‐Berka, J. L. (2015) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0363-z · Cited by 77 · see citing works

Pathophysiology of gadolinium-associated systemic fibrosis

Wagner, B., Drel, V. R., & Gorin, Y. C. (2016) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00166.2016 · Cited by 74 · see citing works

Antifibrotic Therapies in the Liver

Schuppan, D., & Mehal, W. Z. (2015) · Seminars in Liver Disease · doi:10.1055/s-0035-1550055 · Cited by 75 · see citing works

The rationale for targeting TGF ‐β in chronic liver diseases

Giannelli, G., Mikulits, W., Dooley, S., Fabregat, I., Moustakas, A., ten Dijke, P., Portincasa, P., Winter, P., Janssen, R. A. J., Leporatti, S., et al. (2016) · European Journal of Clinical Investigation · doi:10.1111/eci.12596 · Cited by 75 · see citing works

Role of renin-angiotensin system in liver diseases: an outline on the potential therapeutic points of intervention

Ahmadian, E., Pennefather, P., Eftekhari, A., Heidari, R., & Eghbal, M. A. (2016) · Expert Review of Gastroenterology & Hepatology · doi:10.1080/17474124.2016.1207523 · Cited by 73 · see citing works

Nicotinamide adenine dinucleotide phosphate (NADPH) oxidase (NOX) and liver fibrosis: A review

Mortezaee, K. (2018) · Cell Biochemistry and Function · doi:10.1002/cbf.3351 · Cited by 72 · see citing works

The Nox1/4 Dual Inhibitor GKT137831 or Nox4 Knockdown Inhibits Angiotensin‐II‐Induced Adult Mouse Cardiac Fibroblast Proliferation and Migration. AT1 Physically Associates With Nox4

Somanna, N. K., Valente, A. J., Krenz, M., Fay, W. P., Delafontaine, P., & Chandrasekar, B. (2015) · Journal of Cellular Physiology · doi:10.1002/jcp.25210 · Cited by 71 · see citing works

TGF-β in Hepatic Stellate Cell Activation and Liver Fibrogenesis: Updated

Dewidar, B., Soukupová, J., Fabregat, I., & Dooley, S. (2015) · Current Pathobiology Reports · doi:10.1007/s40139-015-0089-8 · Cited by 71 · see citing works

Dermal delivery of HSP47 siRNA with NOX4-modulating mesoporous silica-based nanoparticles for treating fibrosis

Morry, J., Ngamcherdtrakul, W., Gu, S., Goodyear, S. M., Castro, D. J., Reda, M. M., Sangvanich, T., & Yantasee, W. (2015) · Biomaterials · doi:10.1016/j.biomaterials.2015.07.005 · Cited by 71 · see citing works

Extracellular matrix remodelling in obesity and metabolic disorders

Musale, V., Wasserman, D. H., & Kang, L. (2023) · Life Metabolism · doi:10.1093/lifemeta/load021 · Cited by 76 · see citing works

Maresin 1 mitigates concanavalin A-induced acute liver injury in mice by inhibiting ROS-mediated activation of NF-κB signaling

Zhang, P., Yin, Y., Wang, T., Li, W., Li, C., Zeng, X., Yang, W., Zhang, R., Tang, Y., Shi, L., et al. (2019) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2019.11.033 · Cited by 69 · see citing works

Integrin β 1: A Mechanosignaling Sensor Essential for Connective Tissue Deposition by Fibroblasts

Leask, A. (2013) · Advances in Wound Care · doi:10.1089/wound.2012.0365 · Cited by 67 · see citing works

Strategies and endpoints of antifibrotic drug trials: Summary and recommendations from the AASLD Emerging Trends Conference, Chicago, June 2014

Torok, N. J., Dranoff, J. A., Schuppan, D., & Friedman, S. L. (2015) · Hepatology · doi:10.1002/hep.27720 · Cited by 70 · see citing works

Liver Injury and the Activation of the Hepatic Myofibroblasts

Jiang, J. X., & Torok, N. J. (2013) · Current Pathobiology Reports · doi:10.1007/s40139-013-0019-6 · Cited by 69 · see citing works

Nuclear Factor–Erythroid-2–Related Factor 2 in Aging and Lung Fibrosis

Swamy, S., Rajasekaran, N. S., & Thannickal, V. J. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.02.022 · Cited by 67 · see citing works

Microengineered cultures containing human hepatic stellate cells and hepatocytes for drug development

Davidson, M. D., Kukla, D. A., & Khetani, S. R. (2017) · Integrative Biology · doi:10.1039/c7ib00027h · Cited by 66 · see citing works

<scp>Pre‐clinical</scp> evidence of a dual <scp>NADPH</scp> oxidase 1/4 inhibitor (setanaxib) in liver, kidney and lung fibrosis

Thannickal, V. J., Jandeleit‐Dahm, K., Szyndralewiez, C., & Török, N. J. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.17649 · Cited by 65 · see citing works

Ursolic acid ameliorates CCl4‐induced liver fibrosis through the NOXs/ROS pathway

Gan, D., Zhang, W., Huang, C., Jiang, C., He, W., Wang, A., Li, B., & Zhu, X. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26541 · Cited by 65 · see citing works

Backstage players of fibrosis: NOX4, mTOR, HDAC, and S1P; companions of TGF-β

Jiménez‐Uribe, A. P., Gómez‐Sierra, T., Aparicio‐Trejo, O. E., Orozco‐Ibarra, M., & Pedraza‐Chaverrí, J. (2021) · Cellular Signalling · doi:10.1016/j.cellsig.2021.110123 · Cited by 64 · see citing works

A Reactive Oxygen Species–Mediated Loop Maintains Increased Expression of NADPH Oxidases 2 and 4 in Skin Fibroblasts From Patients With Systemic Sclerosis

Spadoni, T., Svegliati, S., Amico, D., Albani, L., Moroncini, G., Avvedimento, E. V., & Gabrielli, A. (2015) · Arthritis & Rheumatology · doi:10.1002/art.39084 · Cited by 64 · see citing works

Anti-fibrotic treatments for chronic liver diseases: The present and the future

Odagiri, N., Matsubara, T., Sato-Matsubara, M., Fujii, H., Enomoto, M., & Kawada, N. (2020) · Clinical and Molecular Hepatology · doi:10.3350/cmh.2020.0187 · Cited by 63 · see citing works

Diabetes Alters Activation and Repression of Pro- and Anti-Inflammatory Signaling Pathways in the Vasculature

Marco, E. D., Gray, S. P., & Jandeleit-Dahm, K. A. M. (2013) · Frontiers in Endocrinology · doi:10.3389/fendo.2013.00068 · Cited by 62 · see citing works

Mitochondria- and NOX4-dependent antioxidant defense mitigates progression to nonalcoholic steatohepatitis in obesity

Greatorex, S., Kaur, S., Xirouchaki, C. E., Goh, P. K., Wiede, F., Genders, A., Tran, M., Jia, Y., Raajendiran, A., Brown, W., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162533 · Cited by 50 · see citing works

Therapeutic pro-fibrogenic signaling pathways in fibroblasts

Cannito, S., Novo, E., & Parola, M. (2017) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.05.017 · Cited by 60 · see citing works

Oxidative Stress Induced by Reactive Oxygen Species (ROS) and NADPH Oxidase 4 (NOX4) in the Pathogenesis of the Fibrotic Process in Systemic Sclerosis: A Promising Therapeutic Target

Piera-Velázquez, S., & Jiménez, S. A. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10204791 · Cited by 60 · see citing works

Therapeutic Targeting of Redox Signaling in Myofibroblast Differentiation and Age-Related Fibrotic Disease

Sampson, N., Berger, P., & Zenzmaier, C. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/458276 · Cited by 60 · see citing works

Hepatitis C Virus NS5A Protein Triggers Oxidative Stress by Inducing NADPH Oxidases 1 and 4 and Cytochrome P450 2E1

Smirnova, O. A., Ivanova, O. N., Bartosch, B., Треворович, В.-Э. В., Mukhtarov, F., Kochetkov, S. N., & Ivanov, A. V. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/8341937 · Cited by 60 · see citing works

Molecular Activation of the NLRP3 Inflammasome in Fibrosis: Common Threads Linking Divergent Fibrogenic Diseases

Artlett, C. M., & Thacker, J. D. (2014) · Antioxidants and Redox Signaling · doi:10.1089/ars.2014.6148 · Cited by 59 · see citing works

The pathogenesis, models and therapeutic advances of primary biliary cholangitis

Li, H., Guan, Y., Han, C., Zhang, Y., Liu, Q., Wei, W., & Ma, Y. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2021.111754 · Cited by 58 · see citing works

A bioinformatic and mechanistic study elicits the antifibrotic effect of ursolic acid through the attenuation of oxidative stress with the involvement of ERK, PI3K/Akt, and p38 MAPK signaling pathways in human hepatic stellate cells and rat liver

Zhou, S., Li, W., Shi, F., Zhou, Z.-W., Li, B., Zhang, K., Zhang, X., Ouyang, C., & Zhu, X. (2015) · Drug Design Development and Therapy · doi:10.2147/dddt.s85426 · Cited by 58 · see citing works

Dietary Fisetin Supplementation Protects Against Alcohol‐Induced Liver Injury in Mice

Sun, Q., Zhang, W., Zhong, W. H., Sun, X., & Zhou, Z. (2016) · Alcoholism Clinical and Experimental Research · doi:10.1111/acer.13172 · Cited by 58 · see citing works

Pharmacological inhibition of NOX4 ameliorates alcohol-induced liver injury in mice through improving oxidative stress and mitochondrial function

Sun, Q., Zhang, W., Zhong, W. H., Sun, X., & Zhou, Z. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.09.009 · Cited by 56 · see citing works

The NOX1/4 Inhibitor GKT136901 as Selective and Direct Scavenger of Peroxynitrite

Schildknecht, S., Weber, A., Gerding, H., Pape, R., Robotta, M., Drescher, M., Marquardt, A., Daiber, A., Ferger, B., & Leist, M. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990179 · Cited by 55 · see citing works

NOX as a Therapeutic Target in Liver Disease

Matuz‐Mares, D., Vázquez‐Meza, H., & Vilchis‐Landeros, M. M. (2022) · Antioxidants · doi:10.3390/antiox11102038 · Cited by 55 · see citing works

Redox Signaling as a Therapeutic Target to Inhibit Myofibroblast Activation in Degenerative Fibrotic Disease

Sampson, N., Berger, P., & Zenzmaier, C. (2014) · BioMed Research International · doi:10.1155/2014/131737 · Cited by 54 · see citing works

Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation

Lan, T., Kisseleva, T., & Brenner, D. (2015) · PLoS ONE · doi:10.1371/journal.pone.0129743 · Cited by 192 · see citing works

RESEARCH ARTICLE Deficiency of NOX1 or NOX4 Prevents Liver Inflammation and Fibrosis in Mice through Inhibition of Hepatic Stellate Cell Activation

Lan, T., Kisseleva, T., & Brenner, D. A. (2016)

Nicotinamide adenine dinucleotide phosphate oxidase in experimental liver fibrosis: GKT137831 as a novel potential therapeutic agent

Aoyama, T., Paik, Y.-H., Watanabe, S., Laleu, B., Gaggini, F., Fioraso-Cartier, L., Molango, S., Heitz, F., Merlot, C., Szyndralewiez, C., et al. (2012) · Hepatology · doi:10.1002/hep.25938 · Cited by 336 · see citing works

NADPH Oxidase NOX4 Mediates Stellate Cell Activation and Hepatocyte Cell Death during Liver Fibrosis Development

Sancho, P., Mainez, J., Crosas-Molist, E., Roncero, C., Fernández-Rodríguez, C., Pinedo, F., Huber, H., Eferl, R., Mikulits, W., & Fabregat, I. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045285 · Cited by 157 · see citing works

Role and Cellular Source of Nicotinamide Adenine Dinucleotide Phosphate Oxidase in Hepatic Fibrosis

Minicis, S. D., Seki, E., Paik, Y., Österreicher, C. H., Kodama, Y., Kluwe, J., Torozzi, L., Miyai, K. N., Benedetti, A., Schwabe, R. F., et al. (2010) · Hepatology · doi:10.1002/hep.23804 · Cited by 83 · see citing works